|Oral, intranasal, vaporization, intravenous, rectal, sublingual, subcutaneous|
|Chemical and physical data|
|Molar mass||245.366 g·mol−1|
|3D model (JSmol)|
α-Pyrrolidinohexiophenone (α-PHP, alpha-PHP, α-Pyrrolidinohexanophenone, PV-7) is a synthetic stimulant drug of the cathinone class developed in the 1960s which has been reported as a novel designer drug.
α-Pyrrolidinohexiophenone is a longer chain homologue of α-PVP, having an extra carbon on the alkyl side chain. Regarding the potency of alpha-PHP in the brain, chemist Michael H. Baumann of the Designer Drug Research Unit (established by Baumann) of the National Institute on Drug Abuse stated: "alpha-PHP might be even more potent than alpha-PVP"; this statement is based on laboratory tests of chemical reactivity.
Sweden's public health agency suggested to classify α-PHP as narcotic on June 1, 2015.
As of October 2015, α-PHP is a controlled substance in China.